NCT06120764

Brief Summary

The goal of this randomized controlled study is to assess the effect of guided imagery on chemotherapy-related nausea and vomiting in pediatric oncology patients. Participants will receive either guided imagery+routine care or routine care. The researchers will compare nausea and vomiting and vital signs between groups.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
6mo left

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress84%
Nov 2023Oct 2026

First Submitted

Initial submission to the registry

November 2, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
3 days until next milestone

Study Start

First participant enrolled

November 10, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2026

Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

2.9 years

First QC Date

November 2, 2023

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Nausea and vomiting

    Nausea and Vomiting Thermometer Scale in Children with Cancer is a 5-likert type scale. An increase in the score indicates an increase in the degree of nausea and vomiting experienced by children with cancer.

    30 minutes before the procedure, halfway through the chemotherapy infusion, immediately after the procedure, and for the first 24 hours after the end of chemotherapy

Secondary Outcomes (5)

  • Heart rate

    30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure,

  • Systolic and diastolic blood pressure

    30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure

  • Respiratory rate

    30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure

  • Body temperature

    30 minutes before the procedure, halfway through the chemotherapy infusion, and immediately after the procedure

  • Oxygen saturation

    change from baseline 60 minutes of chemotherapy infusion

Study Arms (2)

Guided imagery group

EXPERIMENTAL

Participants will receive guided imagery intervention.

Other: guided imagery

Control

NO INTERVENTION

Participants will receive routine care.

Interventions

The children in the experimental group will listen to the first part of the 'Guided Imagery CD' prepared by the Turkish Psychological Association for relaxation 30 minutes before the chemotherapy infusion starts. The suggestions given in the first part of the CD will help the patients relax and focus their attention on their breathing. Patients will be positioned in a supine or semi-fowler position and will listen to the CD with headphones from a laptop. Once the chemotherapy infusion starts, relaxing light background music with the sound of a river or sea will be played based on the patients' preference, and imagery will be applied to the patients. Patients will be encouraged to think of various images, such as imagining that the treatment is over, visualizing themselves as much healthier and recovering quickly, returning to their old life, and doing whatever they want to do first after recovery. If there is an object, person, event, situation, or food that will make them feel good,

Guided imagery group

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • to 18 years old,
  • who will receive intravenous chemotherapy,
  • no cognitive or neurological disease that would prevent communication,
  • receiving a chemotherapy protocol with a high or moderate emetogenic effect according to the MASCC/ESMO Antiemetic Guideline Classification,
  • no verbal, visual and auditory communication disabilities (ability to speak Turkish, no mental deficiency),
  • children whose parents and themselves volunteered to participate in the study

You may not qualify if:

  • Children receiving radiotherapy,
  • taking ginger powder or vitamins to reduce nausea,
  • children who did not want to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hacettepe University İhsan Doğramacı Hospital

Ankara, Ankara, 06100, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

VomitingNeoplasms

Interventions

Imagery, Psychotherapy

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Mind-Body TherapiesComplementary TherapiesTherapeuticsPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Ayşe Ay, RN, PhD

    Baskent University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ayşe Ay, RN, PhD

CONTACT

Yağmur Sezer Efe, RN, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participant will be randomly assigned to groups. An independent statistician will analyze the data.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The children in the experimental group will listen to the "Guided Imagery CD" prepared by the Turkish Psychological Association for relaxation 30 minutes before the chemotherapy infusion started and during the chemotherapy infusion. In the meantime, patients will be encouraged to think of various images, such as imagining that the treatment is over, returning to their old life quickly, etc.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RN, PhD, Assistant Professor

Study Record Dates

First Submitted

November 2, 2023

First Posted

November 7, 2023

Study Start

November 10, 2023

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

October 30, 2026

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

the data wil be shared upon a reasonable request.

Locations